Danske Bank: Acquisition of Icelandic wound care company will boost sales at Coloplast

However, the Danish bank sees less share price potential in the Coloplast stock than before.
Photo: Kerecis / Pr
Photo: Kerecis / Pr
by marketwire

Danske Bank has lowered its share price target for Coloplast to DKK 935 (USD 134.23) from DKK 1030 (USD 149.16), citing higher weighted average cost of capital and a larger number of shares after the almost DKK 9bn (USD 1.29bn) acquisition of the Icelandic wound care company Kerecis.

Already a subscriber?Log in here

Read the whole article

Get access for 14 days for free. No credit card is needed, and you will not be automatically signed up for a paid subscription after the free trial.

With your free trial you get:

  • Access all locked articles
  • Receive our daily newsletters
  • Access our app
Must be at least 8 characters, including three of: Uppercase, lowercase, numbers, symbols
Must contain at least 2 characters
Must contain at least 2 characters

Get full access for you and your coworkers

Start a free company trial today

Share article

Sign up for our newsletter

Stay ahead of development by receiving our newsletter on the latest sector knowledge.

Newsletter terms

Front page now

Further reading